Malini Iyer
Associate Director, Oncology Safety & Discovery AstraZeneca
Malini Iyer is an Associate Director in Oncology Safety Science, leading global safety strategy for next generation cancer therapeutics. She drives cross functional decision making by integrating complex preclinical and clinical data to anticipate risks and accelerate development of safer, more effective medicines. Known for her strategic leadership and collaborative influence, Malini shapes safety frameworks that guide programs from early discovery through clinical translation. She partners with multidisciplinary teams to enable innovation while maintaining scientific rigor, ensuring that emerging oncology modalities advance with clarity, confidence, and patient centered focus.
Seminars
Monday 12th October 2026
Evaluating Strategies to Assess Safety Profile of Novel ADC Payloads Under Accelerated Platform Development
- Understanding strategies to accelerate development cycle for novel ADC linker-payloads
- Defining the importance of safety profiles of novel payloads, contextualized through assessment of free payload versus ADC tolerability comparison
- Evaluating in vitro assays to employ for early payload safety profiling leading up to in vivo studies
